News

The Dermatology Innovation Forum, a one-day pre-AAD meeting, gives physicians a frontline seat to founder stories, new innovations and major advances happening currently in dermatology. Here are some of the highlights from the 2019 DIF conference.

New research reports data on the effects the PFD patch has on thermal injury of the epidermis as well as airborne particle emissions.

According to this expert, honesty is the best policy – especially when appealing to insurance carriers on behalf of your patients.

A recent study aimed to explore whether patients suffering from psoriasis carry serious medical morbidity, including cancer, that is not detected through history, physical exam and laboratory studies. 

The science looking at potential harmful effects of e-cigarettes is lagging, as e-cigarette popularity soars and consumer marketing takes hold convincing consumers that e-cigarettes are the safer of the two.

Researchers have developed a device that may eliminate the need for maps, guidelines or manual skin tension estimation techniques.

In many ways, 2018 was a banner year for new novel drug approvals with 59 drugs approved by the FDA’s Center for Drug Evaluation and Research (CDER). Learn about the innovative drugs that were approved for dermatological indications in this article. 

Key developments among new and emerging treatments for acne and rosacea include a novel oral agent and a novel topical agent, as well as new formulations of existing products, says Diane S. Berson, M.D. in her presentation at AAD.

Scars caused by acne can be both physical and emotional. Helping patients get the care they need starts with recognizing and addressing psychosocial issues that can be caused by acne, says Jonette E. Keri, M.D., Ph.D.

Oral contraceptive pills and antiandrogen therapies may rival antibiotics for women with acne, according to research presented by Rachel V. Reynolds, M.D. at AAD earlier this month.

Staphylococcus aureus infections are becoming more challenging to treat due to methicillin-resistant Staphylococcus aureus (MRSA). A better understanding of cutaneous immune mechanisms will identify specific immune mechanisms to target for future vaccines and immunotherapies to ultimately address this serious public health threat.

Consumer demand for body-shaping procedures stands out in newly released ASPS member stats.

Are cosmetic surgeons fostering the opioid epidemic?

Expert calls for FDA approval of devices for women’s genitourinary health: “Women need these treatments.”

Chief executive officer of Can-Fite Biopharmaceuticals, Pnina Fishman, Ph.D. discovered why cancer and inflammation can go everywhere in the body, except muscle tissue. Using this knowledge, Can-Fite has developed a promising psoriasis drug, piclidenoson, which is currently in phase 3 clinical trials.

Leadership and representation are becoming more important as the profession and demand for PAs grow. However, a recent study found that career satisfaction does not appear to be related to professional development benefits offered by employers. What fulfills physician assistants? Participate in this forum.

Learn how the Food and Drug Administration (FDA) plays a critical role in the oversight of many medical devices used commonly in dermatology. 

From lasers to light therapy to non-laser-based thermal tightening, learn each devices' indications, adverse effects and important treatment takeaways.

Drug-device combination, VP-102, met all primary and secondary endpoints in the parallel Cantharidin Application in Molluscum Patients (CAMP)-1 and CAMP-2 trials.

Psoriasis treatment has expanded dramatically over the past decade, and the growth shows no signs of stopping. Andrew Blauvelt, M.D. discussed new drugs in the pipeline during American Academy of Dermatology Annual Meeting in Washington, D.C.

To help providers have a greater understanding of the efforts of the FDA to ensure all drugs are of pharmaceutical quality, Michael Kopcha, Ph.D., RPh, director of the FDA’s Office of Pharmaceutical Quality presented on the topic during the American Academy of Dermatology’s Annual Meeting in Washington, D.C.

Laura Marquart, M.D., FAAD, medical officer with the FDA’s Center for Devices and Radiological Health (CDRH), reviewed how the FDA approaches, reviews, and approves medical devices integral to dermatologic care at the American Academy of Dermatology’s annual meeting in Washington, D.C. Learn how this process can affect patient care in this article.

Longer-lasting treatment for vitiligo could be available within the next few years, according to research presented at the American Academy of Dermatology Annual Meeting in Washington, D.C.

Treating chronic inflammatory skin conditions during pregnancy can be difficult because the therapies dermatologists prescribe can affect the unborn infant. See what insights this physician offers on managing chronic inflammatory skin conditions in pregnant patients.

Dr. Jacob Mashiah offers tips for optimally treating patients with sweating disease.

How was the 2019 Dermatology Hall of Fame Executive Board appointed? Find out in this article. 

In this article, Joseph C English III, M.D., professor of dermatology at the University of Pittsburgh, offers his insight for diagnosing and treating cutaneous blistering diseases. Participate in this forum.

Organic and microbiome friendly cosmeceuticals are two big trends to watch out for in 2019, according to this physician. 

Dermatology care for women goes beyond skin. Practicing dermatologists reside at the crux of meeting women’s needs and play an important role in addressing issues like aging, self-esteem, hormones and stress management.